TIFFANY STRICKLAND: Open Payments
NPI 1679251623 · MADISON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 17 payments from 13 companies in 2025. Trend: 2023 $112 · 2024 $306 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $50 |
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: GEMTESA, VRAYLAR, NURTEC ODT, LEQVIO, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Auvelity.
Industry payments across FL — which companies pay providers there.
